Study in Patients With Breast Cancer Leptomeningeal Metastasis

Recruiting now

Conditions studied: Leptomeningeal Metastasis of Breast Cancer

In brief

Traditional clinical trials in patients with breast cancer leptomeningeal disease (LMD) are challenging as patients often have a rapidly progressive course and prognosis is poor, making meeting standard eligibility difficult. Furthermore, there is limited information about the biology of LMD. The investigators thus propose a study that is as inclusive as possible, which will allow the investigators to collect biospecimens and clinical outcomes to learn more about LMD biology, but still potentially provide benefit for patients, by providing patients rapid diagnostics and multi-disciplinary treatment recommendations.

Key facts

Study ID
NCT06638294
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
People needed
30
Starts
2024-11-25
Expected to finish
2028-12-01
Last updated by the study team
2025-11-28

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.